Genetic study of brain lesions
Part of Brain & nervous system, Cancer clinical trials.
This trial looks at the genetic and molecular features of brain lesions to better understand them. It may help find new ways to diagnose or treat these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had surgery for a brain lesion, such as a glioma, meningioma, or another rare tumor.
- You or your legal guardian agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special microscope to study how brain tissues communicate and signal. It will look at brain tissue taken during surgery (from certain tumor or brain disease cases) to better understand brain wiring and improve reading of lab signals.
This study collects biological samples from adults with a confirmed brain tumor. Samples may help researchers better understand brain tumors and improve future treatments.
This trial uses a special MRI scan to study the genetics of gliomas (a type of brain tumor). It may help doctors better understand your tumor and choose the right treatment. You can join if you have a suspected or confirmed low- or high-grade glioma that still has a measurable tumor after surgery.
This study looks at genetic diseases that affect the immune system and the brain. It aims to better understand these conditions by comparing patients, their relatives, and healthy controls.
This is an observational study that collects and compares information from patients with primary brain tumors and their treatment results. It uses stored tumor tissue and brain scans to better understand outcomes using updated tumor classification methods.
This study follows people with a confirmed genetic nerve or brain disease over time, collecting blood and sometimes spinal fluid samples to learn more about the condition. It may help researchers understand how the disease progresses.
Hear when a new Brain Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.